Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More
After a brutal sell-off erased Wednesday's rally and dragged the Nasdaq back into correction territory, Wall Street analysts are still moving. Some reversed course on Pfizer, Molson Coors, and BJ's, while others spotted fresh opportunities worth a closer look.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Pre-Market Stock Futures:
Futures are mixed this Friday morning, with the Dow Jones trading lower, but Nasdaq futures are higher as AI stocks catch a bid after the big post-election rally turned into a massive post-election sell-off. Concerns over Artificial Intelligence and Data Center spending drove the selling, and stocks that were already overbought heading into third-quarter earnings, and even more so after they finished up, headed south in a big way. Yesterday’s sell-off wiped out Wednesday’s huge rally, and it makes sense for investors who raised cash, as we suggested in the summer and early fall, to start sniffing around for technology bargains.
All of the major indices finished lower Thursday, with the Nasdaq leading the way down and closing once again in correction territory at 24,314, down a stunning 5.52%, while the small-cap Russell 2000 wasn’t far behind, ending the session at 2,729, down 4.45%. The S&P 500 took part in the rout, closing at 7,353, down 4.36%, and the Dow Jones Industrial finished as the best of the worst, down 3.44% to 51,523. Despite positive economic news, concerns over Democrats controlling Congress were a big reason for Thursday’s stock meltdown. Today, traders will watch the October non-farm payroll numbers, and next week inflation data from the consumer and producer price indices will hit the tape.
24/7 Wall St. reviews dozens of analyst research reports every day to identify fresh investment ideas for investors and traders alike. These daily analyst notes include recommendations on stocks to buy, sell, or avoid, as well as new coverage initiations. Important reminder: No single analyst report should ever be the sole basis for buying or selling a stock.
Here are some of the top Wall Street analyst upgrades, downgrades, and initiations from Friday, November 6, 2026.
Upgrades:
- American States Water Company (NYSE: AWR) was upgraded to Buy from Hold at Freedom Broker, which bumped the price target to $99 from $89.
- Becton Dickinson & Company (NYSE: BDX | BDX Price Prediction) was upgraded to Overweight from Equal Weight at Wells Fargo, which lifted the target price to $242 from $170.
- JinkoSolar Holdings (NYSE: JKS) was upgraded to Buy from Neutral at UBS, which lowered the target price for the shares to $17 from $24.
- SiTime NASDAQ: SITM) was upgraded to Buy from Neutral at Seaport Research, with a $425 target price.
- Steven Madden Ltd. (NASDAQ: SHOO) was raised to Hold from Underperform at Jefferies, with an unchanged $36 target price.
Downgrades:
- BJ’s Wholesale Club (NYSE: BJ) was downgraded to Neutral from Buy at Citigroup, which nudged the target price to $113 from $111.
- Cogent Communications (NASDAQ: CCOI) was downgraded to Sector Weight from Overweight at KeyBanc, without a price target.
- Five9 (NASDAQ: FIVN) was downgraded to In Line from Outperform at Evercore ISI, with an unchanged $24 target price.
- Molson Coors Beverage Company (NYSE: TAP) was cut to Underweight from Equal Weight at Wells Fargo, which trimmed the target price for the beer giant to $36 from $38.
- Pfizer (NYSE: PFE) was downgraded to Hold from Buy at DZ Bank, with a $33 target price.
Initiations:
- Eversource Energy (NYSE: ES) was resinstated with an Equal Weight rating at Barclays , with a $76 target price.
- Fervo Energy (NASDAQ: FRVO) was started with a Buy rating at Needham, with a $17 target price.
- Keel Infrastructure (NASDAQ: KEEL) was initiared with a Neutral rating at Goldman Sachs with a $2 target price.
- NovaGold Resources (NYSE: NG) was resumed with a Buy rating at Citigroup, with a $12.50 price target.
- Yarrow Bioscience (NASDAQ: YARW) was initated with a Buy rating at Guggenehim, which has a $60 target for the shares.
Contact [email protected] for any questions or corrections.
Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.
Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.
Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.
Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.
